慢性支气管炎急性发作期发病机制及药物治疗研究进展
Research Progress on Pathogenesis and Drug Therapy in Acute Episode of Chronic Bronchitis
DOI: 10.12677/TCM.2021.103059, PDF,    科研立项经费支持
作者: 高 尚：湖南中医药大学，中药民族药物创新发展国际实验室，湖南 长沙；湖南安邦制药股份有限公司，湖南 长沙；屈金艳, 易小兰, 李艳波, 文复权：湖南安邦制药股份有限公司，湖南 长沙；王 炜*：湖南中医药大学，中药民族药物创新发展国际实验室，湖南 长沙
关键词: 慢性支气管炎；急性发作；发病机制；药物；Chronic Bronchitis； Acute Episode； Pathogenesis； Drug
摘要: 慢性支气管炎是一种发病率高、病程长、易反复发作的疾病，且易发展成为慢性阻塞性肺疾病(COPD)，严重危害患者健康，因此采取适宜措施有效控制缓解慢性支气管炎的急性发作期具有十分重要的意义。在慢性支气管炎防治方面，中医药的优势和特色被临床认可，作者将对疾病急性发作期发病机制及药物治疗的最新进展进行分析、归纳总结，以期为该病的临床治疗提供更多依据和参考。
Abstract: Chronic bronchitis is a disease with high incidence, long course and easy to relapse, and can easily turn into COPD, which badly harms to patients’ health. Therefore, it is of great significance to take appropriate measures to effectively control and alleviate the acute episode of chronic bronchitis. In the field of bronchitis prevention and treatment, the advantages and characteristics of traditional Chinese medicine have been recognized clinically. In order to provide more evidences and references for the clinical treatment of the disease, the author will analyze and summarize the latest progress of the pathogenesis and the drug therapy of the disease in acute episode.
文章引用：高尚, 屈金艳, 易小兰, 李艳波, 文复权, 王炜. 慢性支气管炎急性发作期发病机制及药物治疗研究进展[J]. 中医学, 2021, 10(3): 420-426. https://doi.org/10.12677/TCM.2021.103059

参考文献

[1] 朱婴. 中医药治疗慢性支气管炎的研究进展[J]. 中医临床研究, 2017, 9(25): 142-144.
[2] 倪晓红. 慢性支气管炎加强循证护理干预对患者生存质量影响分析[J]. 大家健康(下旬版), 2014(5): 240.
[3] 罗舒文, 高兴亮, 陈龙全, 杨昌邦, 周诗立, 李沿君, 牟艳林. 慢性支气管炎的中西医结合治疗进展[J]. 湖北民族学院学报(医学版), 2019, 36(1): 75-77.
[4] 毛静. 慢性支气管炎急性加重期的临床治疗分析[J]. 中国医药指南, 2019, 17(12): 125-126.
[5] 史国欣. 慢性支气管炎、慢性肺源性心脏病、COPD患者不同时期BNP、肺功能、动脉血气的变化情况分析[J]. 社区医学杂志, 2015, 13(11): 56-58.
[6] 史利卿, 马建岭, 杨凯, 季坤, 温绍惠, 林彬. 慢性咳嗽中医病因病机及证候学规律的认识与探讨[J]. 现代中医临床, 2017, 24(5): 1-5.
[7] 杨月东, 苏克雷, 沈建平. 从病因性质探讨咳嗽病中气机改变的机理[J]. 中医药导报, 2018, 24(16): 126-127+133.
[8] 白云苹, 李建生, 李庆磊, 马锦地, 李杭洁. 基于现代名老中医经验的慢性支气管炎病因病机及证素规律研究[J]. 中华中医药杂志, 2017, 32(11): 4921-4924.
[9] 张辉. 慢性支气管炎急性发作期中医证候分布规律及慢支方防治慢性支气管炎机制的实验研究[D]: [硕士学位论文]. 合肥: 安徽中医药大学, 2015.
[10] Panigrahi, A. and Padhi, B.K. (2018) Chronic Bronchitis and Airflow Obstruction Is Associated with Household Cooking Fuel Use among Never-Smoking Women: A Community-Based Cross-Sectional Study in Odisha, India. BMC Public Health, 18, Article No. 924. [Google Scholar] [CrossRef] [PubMed]
[11] Sturm, R. (2013) Theoretical Models for the Simulation of Particle Deposition and Tracheobronchial Clearance in Lungs of Patients with Chronic Bronchitis. Annals of Translational Medicine, 1, Article No. 3. [Google Scholar] [CrossRef] [PubMed]
[12] Vamsee, R.S., Solomon, G.M., Dransfield, M.T. and Rowe, S.M. (2016) Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance. Clinics in Chest Medicine, 37, 147-158. [Google Scholar] [CrossRef] [PubMed]
[13] Bennett, W.D., Henderson, A.G. and Donaldson, S.H. (2016) Hydrator Therapies for Chronic Bronchitis. Lessons from Cystic Fibrosis. Annals of the American Thoracic Society, 13, S186-S190.
[14] Hu, G.P., Zhou, Y.M., Hong, W., Tian, J., Hu, J., Peng, G.Y., et al. (2013) Development and Systematic Oxidative Stress of a Rat Model of Chronic Bronchitis and Emphysema Induced by Biomass Smoke. Experimental Lung Research, 39, 229-240. [Google Scholar] [CrossRef] [PubMed]
[15] 尹珊. 慢性支气管炎的病因病理[J]. 社区医学杂志, 2011, 9(3): 70-71.
[16] Vandevelde, N.M, Tulkens, P.M., Diaz, I.Y., Verhaegen, J., Rodriguez-Villalobos, H., Philippart, I., et al. (2014) Characterisation of a collection of Streptococcus pneumoniae Isolates from Patients Suffering from Acute Exacerbations of Chronic Bronchitis: In Vitro Susceptibility to Antibiotics and Biofilm Formation in Relation to Antibiotic Efflux and Serotypes/Serogroups. International Journal of Antimicrobial Agents, 44, 209-217. [Google Scholar] [CrossRef] [PubMed]
[17] Korytina, G.F., Akhmadishina, L.Z., Viktorova, E.V., Tselousova, O.S., Danilko, K.V., Kochetova, O.V., et al. (2013) Extracellular Matrix Remodeling Genes Polymor-phisms and Risk of Chronic Bronchitis and Recurrent Pneumonia in Children. Journal of Human Genetics, 58, 467-474. [Google Scholar] [CrossRef] [PubMed]
[18] Wang, B.L., Fu, E.Q., Cao, Y.Z., Zhong, Y.X., Fu, G.Q., Tian, X.X., et al. (2013) Effect of Leptin Receptor Mutation on the Development of Chronic Bronchitis. Asia Pacific Journal of Public Health, 25, 80-87. [Google Scholar] [CrossRef] [PubMed]
[19] Wang, P., Naruse, S., Yin, H., Yu, Z.F., Zhuang, T.Q., Ding, W., et al. (2012) The Susceptibility of T5-TG12 of the CFTR Gene in Chronic Bronchitis Occurrence in a Chinese Population in Jiangsu Province, China. The Journal of Biomedical Research, 26, 410-417. [Google Scholar] [CrossRef] 
[20] 葛金芳, 李俊, 姚宏伟. 慢性支气管炎免疫病理机制的研究进展[J]. 安徽医药, 2003, 7(3): 163-166, 175.
[21] Huang, Y., Gao, J., Meng, X.M., Jiang, G.L., Yang, Y.R., Li, H, et al. (2011) Involvement of Mitogen-ACTIVATED protein Kinase Activation in Cyclooxygenase-2 and Transforming Growth Factor-β Production in Alveolar Macrophage from Chronic Bronchitis Rats. Immunopharmacology and Immunotoxicology, 33, 645-651. [Google Scholar] [CrossRef] [PubMed]
[22] Saini, Y., Lewis, B.W., Yu, D.F., Yu, D., Dang, H., Livraghi-Butrico, A., et al. (2018) Effect of LysM+ Macrophage Depletion on Lung Pathology in Mice with Chronic Bronchitis. Physiological Reports, 6, e13677. [Google Scholar] [CrossRef] [PubMed]
[23] 范明华, 张铭, 梁晔, 邵世宏, 赵鹏, 苗玉, 邢广群. 大鼠慢性肺部感染刺激抗中性粒细胞胞质抗体产生及其机制[J]. 中华肾脏病杂志, 2019, 35(8): 603-610.
[24] 刘秀华. 慢性支气管炎的免疫病理机制及药物治疗[J]. 中国医药指南, 2010, 8(13): 197-198.
[25] 甘学军, 汪小华, 胡刚. 慢性支气管炎急性发作期患者血清肿瘤坏死因子α、白介素6水平变化及其临床意义[J]. 实用心脑肺血管病杂志, 2016, 24(5): 127-128.
[26] Zhu, J., Qiu, Y., Valobra, M., Qiu, S., Majumdar, S., Matin, D., et al. (2007) Plasma Cells and IL-4 in Chronic Bronchitis and Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 175, 1125-1133. [Google Scholar] [CrossRef] 
[27] Kesimer, M., Ford, A.A., Ceppe, A., Radicioni, G., Cao, R., Davis, W., et al. (2017) Airway Mucin Concentration as a Marker of Chronic Bronchitis. New England Journal of Medicine, 377, 911-922. [Google Scholar] [CrossRef] 
[28] 万宁, 张建勇, 唐凤鸣, 李永春, 张健, 陈德. TLR4在慢性支气管炎大鼠气道粘液高分泌中的作用及多粘菌素B干预的影响[J]. 西部医学, 2015, 27(12): 1780-1784.
[29] Pace, E., Ferraro, M., Giarratano, A., Cipollina, C. and Gjomarkaj, M. (2013) TLR4 Up-Regulation and Reduced Foxp3 Expression in Mechanically Ventilated Smokers with Obstructive Chronic Bronchitis. COPD: Journal of Chronic Obstructive Pulmonary Disease, 10, 147-155. [Google Scholar] [CrossRef] [PubMed]
[30] 任晓磊. 基于代谢组学的慢性支气管炎发病机理及岩白菜素作用机制研究[D]: [硕士学位论文]. 北京: 北京中医药大学, 2016.
[31] 黄亚林. 野菊花提取物对慢性支气管炎大鼠免疫功能、自由基水平及肺组织病理形态学的影响[J]. 中国社区医师(医学专业), 2012, 14(5): 6.
[32] 张才来, 曾宪辉, 贾龙睿, 钟伟, 杨志武. 二陈汤合三子养亲汤加减治疗慢性支气管炎急性发作21例[J]. 基层医学论坛, 2019, 23(17): 2472-2474.
[33] 金瑞凡. 清金化痰汤加减治疗痰热郁肺型慢性支气管炎急性发作期的临床效果观察[J]. 中外医学研究, 2019, 17(8): 31-32.
[34] 冯焕珍, 区晓芬, 区晓珊. 杏苏散加减治疗痰浊阻肺型慢性支气管炎急性发作期的疗效观察[J]. 齐齐哈尔医学院学报, 2019, 40(16): 2033-2034.
[35] 王丽娟, 王明杰, 孙中莉, 黄亚会, 王飞. 麻杏石甘汤治疗慢性支气管炎急性发作临床研究[J]. 中国中医药现代远程教育, 2017, 15(21): 72-73.
[36] 刘颖慧. 射干麻黄汤对慢性支气管炎急性发作老年患者血清IL-6、PCT、hs-CRP的影响[J]. 中医药临床杂志, 2019, 31(6): 1108-1110.
[37] 刘铁柱, 龚泳梅. 小青龙汤加减治疗慢性支气管炎急性发作期临床疗效观察[J]. 中医临床研究, 2019, 11(5): 30-31+33.
[38] 豆卫卫. 桑白皮汤加减治疗慢性支气管炎急性发作的临床有效率分析[J]. 世界最新医学信息文摘, 2018, 18(A0): 157.
[39] 刘陈. 止嗽散加减治疗慢性支气管炎急性发作60例临床疗效观察[J]. 世界最新医学信息文摘, 2019, 19(30): 310.
[40] 费玲, 赵秋良, 张维维. 疏风解毒胶囊对风热犯肺型慢性支气管炎急性发作患者的影响[J]. 世界中医药, 2020, 15(22): 3439-3442.
[41] 范伏元, 柳玉佳. 银黄清肺胶囊联合阿莫西林克拉维酸钾治疗慢性支气管炎急性发作30例[J]. 中国中医药现代远程教育, 2013, 11(19): 71-72.
[42] 张秀玲, 姚晓轶. 川贝枇杷胶囊联合头孢哌酮治疗慢性支气管炎急性发作的临床研究[J]. 现代药物与临床, 2020, 35(11): 2243-2246.
[43] Sethi, S. (2010) Antibiotics in Acute Exacerbations of Chronic Bronchitis. Expert Review of Anti-Infective Therapy, 8, 405-417. [Google Scholar] [CrossRef] [PubMed]
[44] 于元强. 阿莫西林克拉维酸钾不同给药方法(序贯疗法、静脉滴注)对老年慢性支气管炎急性发作的治疗价值分析[J]. 临床医药文献电子杂志, 2019, 6(45): 25-26.
[45] 童细荣. 阿奇霉素联合左氧氟沙星治疗慢性支气管炎急性发作的临床疗效[J]. 临床合理用药杂志, 2019, 12(9): 60-61.
[46] Anzueto, A. and Miravitlles, M. (2010) Short-Course Fluoroquinolone Therapy in Exacerbations of Chronic Bronchitis and COPD. Respiratory Medicine, 104, 1396-1403. [Google Scholar] [CrossRef] [PubMed]
[47] 盛楠. 盐酸氨溴索治疗慢性支气管炎急性发作的疗效观察[J]. 中国医药指南, 2019, 17(14): 205-206.
[48] 王娜. 沐舒坦与多索茶碱结合对老年慢性支气管炎急性发作患者的疗效分析[J]. 中国医学工程, 2018, 26(7): 92-94.
[49] 谭强. 乙酰半胱氨酸治疗慢性支气管炎急性发作期患者的临床疗效观察[J]. 中国现代药物应用, 2019, 13(11): 118-119.
[50] 谢文卓. 胸腺肽联合抗生素治疗老年慢性支气管炎急性发作期疗效观察[J]. 现代诊断与治疗, 2017, 28(23): 4360-4361.
[51] 刘树海. 头孢呋辛钠联合氨溴索治疗老年慢性支气管炎急性发作临床分析[J]. 临床医药文献电子杂志, 2017, 4(68): 13406-13407.
[52] 李廷灿, 叶瑞航, 骆国勇. 孟鲁司特钠联合复方甲氧那明治疗慢性支气管炎效果分析[J]. 首都食品与医药, 2019, 26(21): 55-56.
[53] 朱应福. 盐酸氨溴索注射液联合羧甲司坦口服液治疗慢性支气管炎的疗效观察[J]. 心理月刊, 2019, 14(19): 179-180.
[54] 杨晓华. 左氧氟沙星联合氨溴索对慢性支气管炎患者肺功能及生活质量的应用观察[J]. 世界最新医学信息文摘, 2019, 19(29): 103-104.
[55] Yakoot, M., Salem, A. and Omar, A.-M. (2010) Clinical Efficacy of Farcosolvin Syrup (Ambroxol-Theophylline- Guaiphenesin Mixture) in the Treatment of Acute Exacerbation of Chronic Bronchitis. International Journal of Chronic Obstructive Pulmonary Disease, 5, 251-256. [Google Scholar] [CrossRef] 
[56] 黄坤, 刘正阳. 抗生素针对性用药治疗老年慢性支气管炎急性加重期的临床效果观察[J]. 临床合理用药杂志, 2019, 12(23): 52-53.
[57] 王逸飞. 浅谈超级细菌的耐药性及诊疗机制[J]. 临床医药文献电子杂志, 2016, 3(40): 8087-8088.
[58] 陈亚乔, 侯林, 崔清华, 刘相文, 袁琦, 张成华, 田景振. 中药抗病毒活性及作用机制研究进展[J]. 中医药导报, 2017, 23(22): 103-106.